Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2006 Mar 29;63(11):1226–1235. doi: 10.1007/s00018-005-5597-y

Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance

Y Balaraman 1,, A R Limaye 1, A I Levey 2, S Srinivasan 1
PMCID: PMC11136440  PMID: 16568235

Abstract.

Alzheimer’s disease (AD) is a neurodegenerative disorder associated with cognitive and behavioral dysfunction and is the leading cause of dementia in the elderly. Several studies have implicated molecular and cellular signaling cascades involving the serine-threonine kinase, glycogen synthase kinase β(GSK-3β) in the pathogenesis of AD. GSK-3β may play an important role in the formation of neurofibrillary tangles and senile plaques, the two classical pathological hallmarks of AD. In this review, we discuss the interaction between GSK-3β and several key molecules involved in AD, including the presenilins, amyloid precursor protein, tau, and β-amyloid. We identify the signal transduction pathways involved in the pathogenesis of AD, including Wnt, Notch, and the PI3 kinase/Akt pathway. These may be potential therapeutic targets in AD.

Keywords. Alzheimer’s disease, glycogen synthase kinase 3β, amyloid precursor protein, presenilins, tau, β-amyloid, neuronal apoptosis, lithium.

Footnotes

Received 19 December 2005; received after revision 24 January 2006; accepted 6 February 2006


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES